Introduction Female Reproductive to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0P728
Introduction Female Reproductive to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0P729
Introduction Female Reproductive to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0P73Z
Introduction Female Reproductive to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0P76Z
Introduction Female Reproductive to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0P77Z
Introduction Female Reproductive to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0P7BZ
Introduction Female Reproductive to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0P7GC
Introduction Female Reproductive to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0P7HZ
Introduction Female Reproductive to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0P7KZ
Introduction Female Reproductive to No Qualifier with Sperm, Via Natural or Artificial Opening Approach - 3E0P7LZ
Introduction Female Reproductive to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0P7NZ
Introduction Female Reproductive to Autologous with Fertilized Ovum, Via Natural or Artificial Opening Approach - 3E0P7Q0
Introduction Female Reproductive to Nonautologous with Fertilized Ovum, Via Natural or Artificial Opening Approach - 3E0P7Q1
Introduction Female Reproductive to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0P7SF
Introduction Female Reproductive to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0P7TZ
Introduction Female Reproductive to No Qualifier with Hormone, Via Natural or Artificial Opening Approach - 3E0P7VZ
Introduction Female Reproductive to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0P804
Introduction Female Reproductive to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0P805
Introduction Female Reproductive to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0P80M
Introduction Female Reproductive to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0P828
Introduction Female Reproductive to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0P829
Introduction Female Reproductive to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0P83Z
Introduction Female Reproductive to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P86Z
Introduction Female Reproductive to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P87Z
Introduction Female Reproductive to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8BZ
Introduction Female Reproductive to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8GC
Introduction Female Reproductive to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8HZ
Introduction Female Reproductive to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8KZ
Introduction Female Reproductive to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8NZ
Introduction Female Reproductive to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8SF
Introduction Female Reproductive to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0P8TZ
Introduction Cranial Cavity and Brain to Liquid Brachytherapy Radioisotope with Antineoplastic, Open Approach - 3E0Q004
Introduction Cranial Cavity and Brain to Other Antineoplastic with Antineoplastic, Open Approach - 3E0Q005
Introduction Cranial Cavity and Brain to Monoclonal Antibody with Antineoplastic, Open Approach - 3E0Q00M
Introduction Cranial Cavity and Brain to Oxazolidinones with Anti-infective, Open Approach - 3E0Q028
Introduction Cranial Cavity and Brain to Other Anti-infective with Anti-infective, Open Approach - 3E0Q029
Introduction Cranial Cavity and Brain to No Qualifier with Anti-inflammatory, Open Approach - 3E0Q03Z
Introduction Cranial Cavity and Brain to No Qualifier with Nutritional Substance, Open Approach - 3E0Q06Z
Introduction Cranial Cavity and Brain to No Qualifier with Electrolytic and Water Balance Substance, Open Approach - 3E0Q07Z
Introduction Cranial Cavity and Brain to No Qualifier with Stem Cells, Embryonic, Open Approach - 3E0Q0AZ
Introduction Cranial Cavity and Brain to No Qualifier with Anesthetic Agent, Open Approach - 3E0Q0BZ
Introduction Cranial Cavity and Brain to Autologous with Stem Cells, Somatic, Open Approach - 3E0Q0E0
Introduction Cranial Cavity and Brain to Nonautologous with Stem Cells, Somatic, Open Approach - 3E0Q0E1
Introduction Cranial Cavity and Brain to Other Substance with Other Therapeutic Substance, Open Approach - 3E0Q0GC
Introduction Cranial Cavity and Brain to No Qualifier with Radioactive Substance, Open Approach - 3E0Q0HZ
Introduction Cranial Cavity and Brain to No Qualifier with Other Diagnostic Substance, Open Approach - 3E0Q0KZ
Introduction Cranial Cavity and Brain to No Qualifier with Analgesics, Hypnotics, Sedatives, Open Approach - 3E0Q0NZ
Introduction Cranial Cavity and Brain to Other Gas with Gas, Open Approach - 3E0Q0SF
Introduction Cranial Cavity and Brain to No Qualifier with Destructive Agent, Open Approach - 3E0Q0TZ
Introduction Cranial Cavity and Brain to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0Q304
Introduction Cranial Cavity and Brain to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0Q305
Introduction Cranial Cavity and Brain to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0Q30M
Introduction Cranial Cavity and Brain to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0Q328
Introduction Cranial Cavity and Brain to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0Q329
Introduction Cranial Cavity and Brain to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0Q33Z
Introduction Cranial Cavity and Brain to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0Q36Z
Introduction Cranial Cavity and Brain to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0Q37Z
Introduction Cranial Cavity and Brain to No Qualifier with Stem Cells, Embryonic, Percutaneous Approach - 3E0Q3AZ
Introduction Cranial Cavity and Brain to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0Q3BZ
Introduction Cranial Cavity and Brain to Autologous with Stem Cells, Somatic, Percutaneous Approach - 3E0Q3E0
Introduction Cranial Cavity and Brain to Nonautologous with Stem Cells, Somatic, Percutaneous Approach - 3E0Q3E1
Introduction Cranial Cavity and Brain to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0Q3GC
Introduction Cranial Cavity and Brain to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0Q3HZ
Introduction Cranial Cavity and Brain to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0Q3KZ
Introduction Cranial Cavity and Brain to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0Q3NZ
Introduction Cranial Cavity and Brain to Other Gas with Gas, Percutaneous Approach - 3E0Q3SF
Introduction Cranial Cavity and Brain to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0Q3TZ
Introduction Cranial Cavity and Brain to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0Q704
Introduction Cranial Cavity and Brain to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0Q705
Introduction Cranial Cavity and Brain to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0Q70M
Introduction Cranial Cavity and Brain to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0Q7SF
Introduction Spinal Canal to No Qualifier with Stem Cells, Embryonic, Open Approach - 3E0R0AZ
Introduction Spinal Canal to Autologous with Stem Cells, Somatic, Open Approach - 3E0R0E0
Introduction Spinal Canal to Nonautologous with Stem Cells, Somatic, Open Approach - 3E0R0E1
Introduction Spinal Canal to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E0R302
Introduction Spinal Canal to Low-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E0R303
Introduction Spinal Canal to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0R304
Introduction Spinal Canal to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0R305
Introduction Spinal Canal to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0R30M
Introduction Spinal Canal to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0R328
Introduction Spinal Canal to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0R329
Introduction Spinal Canal to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0R33Z
Introduction Spinal Canal to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0R36Z
Introduction Spinal Canal to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0R37Z
Introduction Spinal Canal to No Qualifier with Stem Cells, Embryonic, Percutaneous Approach - 3E0R3AZ
Introduction Spinal Canal to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0R3BZ
Introduction Spinal Canal to Autologous with Stem Cells, Somatic, Percutaneous Approach - 3E0R3E0
Introduction Spinal Canal to Nonautologous with Stem Cells, Somatic, Percutaneous Approach - 3E0R3E1
Introduction Spinal Canal to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0R3GC
Introduction Spinal Canal to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0R3HZ
Introduction Spinal Canal to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0R3KZ
Introduction Spinal Canal to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0R3NZ
Introduction Spinal Canal to Other Gas with Gas, Percutaneous Approach - 3E0R3SF
Introduction Spinal Canal to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0R3TZ
Introduction Spinal Canal to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0R7SF
Introduction Epidural Space to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E0S302
Introduction Epidural Space to Low-dose Interleukin-2 with Antineoplastic, Percutaneous Approach - 3E0S303
Introduction Epidural Space to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0S304
Introduction Epidural Space to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0S305
Introduction Epidural Space to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0S30M